RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial

Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial

Add to Collection
RCTs ML Subramanian, G Abedi, S Ness, E Ahmed… - Eye, 2010 - nature.com

Chapter : Section2
Journal Year : 2010
Cited by : 116

… At 1-year follow-up, mean vision was 42.5 letters in the bevacizumab group, and 39.0 letters … Baseline visual acuity and follow-up visions were obtained with Early Treatment Diabetic …..... Read More

Keywords : ['prospective doublemaske randomise clinical trial', 'agerelate macular degeneration outcome', 'bevacizumab vs ranibizumab']
PubMed Link : https://www.nature.com/articles/eye2010147
Google Scholar Link : https://scholar.google.com/scholar?cites=7515265984657552665&as_sdt=40000005&sciodt=0,22&hl=en&num=20